Thierry Bernard

Last updated on 2017-05-12T08:07+0300.

About this image

sign

Quotes... Extracted quotes from

Thierry Bernard said : "The magnitude and duration of the global coronavirus pandemic have proven the increasingly critical importance of molecular testing to society. Qiagen’s business prospects have improved significantly," External link

channelnewsasia Thursday, August 13, 2020 5:30:00 PM EAT

Thierry Bernard said ( about Thermo Fisher Scientific ) : "After carefully considering the updated offer by Thermo Fisher , QIAGEN's Supervisory Board and Managing Board both unanimously recommend that shareholders accept this offer given that it reflects the improvements in our business performance and future prospects as a result of the coronavirus pandemic," External link

4-traders Thursday, July 16, 2020 3:53:00 PM EAT

Thierry Bernard said : “We are pleased to begin making QIAstat-Dx SARS-CoV-2 test kits available in the United States under the FDA’s emergency use authorisation for clinical laboratories. The QIAstat-Dx syndromic panel adds an important tool for clinicians,” External link

labmate-online Thursday, April 2, 2020 2:54:00 PM EAT

Thierry Bernard said : “We are pleased to begin making QIAstat-Dx SARS-CoV-2 test kits available in the United States as the first syndromic test not only to detect SARS-CoV-2, but also a range of more than 20 other respiratory targets. This is an important step in our commitment to offer a range of solutions to support the public health fight against COVID-19 and dramatically ramp up production” External link

neurope Tuesday, March 24, 2020 7:13:00 PM EAT

Thierry Bernard said : “We are pleased to begin making QIAstat-Dx SARS-CoV-2 test kits available in the United States as the first syndromic test not only to detect SARS-CoV-2, but also a range of more than 20 other respiratory targets. This is an important step in our commitment to offer a range of solutions to support the public health fight against COVID-19 and dramatically ramp up production,” External link

4-traders Tuesday, March 24, 2020 1:19:00 PM EAT

Thierry Bernard said : "We are pleased to launch the QIAstat-Dx SARS-CoV-2 test kits in Europe for clinical laboratories. QIAGEN is partnering with customers and public health authorities worldwide to provide a wide range of testing workflows, and the QIAstat-Dx syndromic panel adds an important tool for clinicians," External link

finanznachrichten-en Thursday, March 19, 2020 3:05:00 AM EAT

Thierry Bernard said : "QIAGEN teams are working 24/7 to address the unprecedented demand for reagents that has emerged to enable testing for COVID-19 in terms of RNA extraction, as well as for production of tests for use on the QIAstat-Dx syndromic testing system," External link

finanznachrichten-en Wednesday, March 18, 2020 1:02:00 AM EAT

Thierry Bernard says : "simple cartridge that goes into a very simple reader, which is the size of your laptop," External link

npr Wednesday, March 11, 2020 12:38:00 PM EAT

Thierry Bernard said ( about Thermo Fisher Scientific ) : "This strategic step with Thermo Fisher will enable us to enter a promising new era and will give our employees the opportunity to have an even greater impact. The combination is designed to deliver significant cash value to our shareholders," External link

xinhuanet_en Wednesday, March 4, 2020 2:03:00 AM EAT

Thierry Bernard said : "Our vision at QIAGEN has always been to make improvements in life possible with our differentiated Sample to Insight molecular testing solutions," External link

news-yahoo Tuesday, March 3, 2020 3:22:00 PM EAT

Thierry Bernard said : "Our vision at QIAGEN has always been to make improvements in life possible with our differentiated Sample to Insight molecular testing solutions," External link

news-yahoo Tuesday, March 3, 2020 11:32:00 AM EAT

Thierry Bernard said : "Our vision at QIAGEN has always been to make improvements in life possible with our differentiated Sample to Insight molecular testing solutions," External link

finanznachrichten-en Tuesday, March 3, 2020 11:29:00 AM EAT

Thierry Bernard sagte : "Wir freuen uns über die weitere Zusammenarbeit mit Amgen, denn sie basiert auf dem Erfolg unserer therascreen -Plattform und wird ein gewebebasiertes Begleitdiagnostikum entwickeln, um Patienten zu identifizieren, die von AMG510 profitieren würden. QIAGENs Sample to Insight-Workflows und die Erfahrung in der Entwicklung von Begleitdiagnostika für die Präzisionsmedizin sind sehr gut geeignet, um bei der Beurteilung von Patienten mit nicht-kleinzelligem Lungenkrebs zu helfen" External link

businesswire Tuesday, January 14, 2020 11:28:00 AM EAT

Thierry Bernard said : “We are pleased to support Amgen by building on the success of our therascreen platform to develop a tissue-based companion diagnostic to identify patients who would benefit from AMG510. QIAGEN’s Sample to Insight workflows and experience in developing diagnostic solutions for Precision Medicine are well-suited to help aid in evaluating patients with non-small cell lung cancer,” External link

businesswire Tuesday, January 14, 2020 11:28:00 AM EAT

Thierry Bernard said : "We are pleased to support Amgen by building on the success of our therascreen platform to develop a tissue-based companion diagnostic to identify patients who would benefit from AMG510. QIAGEN's Sample to Insight workflows and experience in developing diagnostic solutions for Precision Medicine are well-suited to help aid in evaluating patients with non-small cell lung cancer," External link

finanznachrichten-en Tuesday, January 14, 2020 1:12:00 AM EAT

Thierry Bernard sagte : "Wir freuen uns über die weitere Zusammenarbeit mit Amgen, denn sie basiert auf dem Erfolg unserer therascreen -Plattform und wird ein gewebebasiertes Begleitdiagnostikum entwickeln, um Patienten zu identifizieren, die von AMG510 profitieren würden. QIAGENs Sample to Insight-Workflows und die Erfahrung in der Entwicklung von Begleitdiagnostika für die Präzisionsmedizin sind sehr gut geeignet, um bei der Beurteilung von Patienten mit nicht-kleinzelligem Lungenkrebs zu helfen" External link

finanznachrichten-en Tuesday, January 14, 2020 1:12:00 AM EAT

Thierry Bernard said : “We are pleased to support Amgen by building on the success of our therascreen platform to develop a tissue-based companion diagnostic to identify patients who would benefit from AMG510. QIAGEN’s Sample to Insight workflows and experience in developing diagnostic solutions for Precision Medicine are well-suited to help aid in evaluating patients with non-small cell lung cancer,” External link

4-traders Tuesday, January 14, 2020 12:15:00 AM EAT

Thierry Bernard said : "2,500 cumulative QIAsymphony placements represent a great milestone for QIAGEN and are proof-point for a new era in laboratory automation that began in 2008. Today, QIAsymphony is considered a trusted workhorse in molecular testing labs worldwide whose continuous enhancements and ongoing menu expansion enabled numerous breakthroughs in science and helped diagnostic decision making to improve outcomes for over a million patients," External link

finanznachrichten-en Friday, January 10, 2020 12:45:00 AM EAT

Thierry Bernard sagte : „Wir freuen uns sehr über die FDA-Zulassung des LIAISON-QuantiFERON-TB Gold Plus Tests für den Einsatz auf der LIAISON-Plattform und den nun folgenden breitangelegten Marktstart dieser neuen Automatisierungsoption in den USA. Durch die Validierung der QuantiFERON-Technologie mit den LIAISON-Plattformen wurde das klinische Profil von QuantiFERON-TB Gold Plus weiter gestärkt“ External link

businesswire Thursday, November 28, 2019 1:08:00 AM EAT

Thierry Bernard said ( about Ekke Primauno ) : “We are pleased to announce FDA approval of the LIAISON QuantiFERON-TB Gold Plus Test for use on the LIAISON platform and the broad-based initiation of our launch for this new automation option in the United States. The validation of the QuantiFERON technology with the LIAISON platforms further reinforced the clinical profile of QuantiFERON-TB Gold Plus,” External link

businesswire Thursday, November 28, 2019 1:08:00 AM EAT

Thierry Bernard said ( about Ekke Primauno ) : “We are pleased to announce FDA approval of the LIAISON QuantiFERON-TB Gold Plus Test for use on the LIAISON platform and the broad-based initiation of our launch for this new automation option in the United States. The validation of the QuantiFERON technology with the LIAISON platforms further reinforced the clinical profile of QuantiFERON-TB Gold Plus,” External link

4-traders Wednesday, November 27, 2019 10:50:00 AM EAT

Thierry Bernard said : "Insights from our QIAstat-Dx syndromic testing solution offer real value for clinicians as rapid and efficient decision support for their evaluation of complex and sometimes life-threatening infections. This new study adds to the rapidly growing base of evidence that the QIAstat-Dx gastrointestinal panel delivers excellent results in an easy-to-use workflow," External link

finanznachrichten-en Wednesday, August 14, 2019 11:33:00 PM EAT

Thierry Bernard said : "We are pleased that UNAIDS selected QuantiFERON-TB Access for recognition at the Health Innovation Exchange. QIAGEN's drive to develop QFT Access springs from the need for a modern, accurate test for TB infection screening in areas where the disease burden is high but resources and infrastructure are scarce," External link

finanznachrichten-en Wednesday, May 22, 2019 1:01:00 AM EAT

Thierry Bernard said : “We are pleased that UNAIDS selected QuantiFERON-TB Access for recognition at the Health Innovation Exchange. QIAGEN’s drive to develop QFT Access springs from the need for a modern, accurate test for TB infection screening in areas where the disease burden is high but resources and infrastructure are scarce,” External link

4-traders Tuesday, May 21, 2019 11:54:00 PM EAT

Thierry Bernard sagt : "Wir freuen uns sehr über die Markteinführung des neuen therascreen FGFR-Kits, dem ersten von der FDA zugelassenen Begleitdiagnosetest zur Ermittlung von Alterationen im FGFR-Gen, der eine zielgerichtete Behandlung von Krebsindikationen ermöglicht. Durch den Einsatz unseres Tests zur Orientierung von Behandlungsentscheidungen bei Urothelkarzinomen wird ein hoher medizinischer Bedarf gedeckt" External link

finanznachrichten-en Saturday, April 13, 2019 7:14:00 AM EAT

Thierry Bernard said : "We are very excited about the launch of the new therascreen FGFR Kit, the first companion diagnostic test to obtain FDA approval for detection of FGFR gene alterations to guide therapy in any cancer indication. Using our test to help guide treatment decisions in urothelial cancer will address a high unmet medical need among patients," External link

finanznachrichten-en Friday, April 12, 2019 11:37:00 PM EAT

Thierry Bernard said : "NeuMoDx is aggressively ramping up the test menu for the NeuMoDx platforms to help clinical laboratories process increasing test volumes and deliver more rapid insights on a broad range of diseases. These new assays offer customers in Europe an expanding menu of infectious diseases, and we intend to continue rolling out new tests from a deep pipeline for a variety of diseases," External link

finanznachrichten-en Friday, April 12, 2019 12:30:00 AM EAT

Thierry Bernard said : "Our new QIAstat-Dx panel meets an urgent need for rapid and reliable diagnosis of meningitis and encephalitis infections, and will enable clinicians to select appropriate therapies in a timely manner. The panel delivers valuable insights with high sensitivity and specificity to identify these life-threatening syndromes," External link

finanznachrichten-en Friday, April 12, 2019 12:30:00 AM EAT

Thierry Bernard erklärte : "Unser neues QIAstat-Dx-Panel deckt den dringenden Bedarf an einer schnellen und zuverlässigen Diagnose von Meningitis/Enzephalitis ab und ermöglicht Ärzten damit die zeitnahe Wahl von geeigneten Therapien. Das Panel liefert wertvolle Erkenntnisse mit hoher Sensitivität und Spezifität für die Erkennung dieser lebensbedrohlichen Syndrome" External link

finanznachrichten-en Friday, April 12, 2019 12:30:00 AM EAT

Thierry Bernard said : “NeuMoDx is aggressively ramping up the test menu for the NeuMoDx platforms to help clinical laboratories process increasing test volumes and deliver more rapid insights on a broad range of diseases. These new assays offer customers in Europe an expanding menu of infectious diseases, and we intend to continue rolling out new tests from a deep pipeline for a variety of diseases,” External link

businesswire Thursday, April 11, 2019 11:36:00 PM EAT

Thierry Bernard said : "Our Day-One Lab Readiness program covers all the steps in being able to begin serving patients with access to companion diagnostic results immediately upon approval of new targeted therapies and the related companion diagnostics. Our Day-One program includes pre-approval preparation of workflow implementation, training, assay verification, forecasting, medical communication and reimbursement to ensure immediate readiness," External link

finanznachrichten-en Wednesday, April 3, 2019 11:57:00 PM EAT

Thierry Bernard said : “Our Day-One Lab Readiness program covers all the steps in being able to begin serving patients with access to companion diagnostic results immediately upon approval of new targeted therapies and the related companion diagnostics. Our Day-One program includes pre-approval preparation of workflow implementation, training, assay verification, forecasting, medical communication and reimbursement to ensure immediate readiness,” External link

businesswire Wednesday, April 3, 2019 11:35:00 PM EAT

Thierry Bernard said : "We are pleased to collaborate with Tecan, a proven leader with a track record of providing best-in-class liquid handling technology solutions, to further improve the automation of the pre-analytic manual steps leading to our QuantiFERON-TB Gold Plus test for customers," External link

finanznachrichten-en Friday, March 8, 2019 10:04:00 AM EAT

Thierry Bernard said : “QuantiFERON-TB Gold Plus is rapidly winning adoption in developed markets as an important way to detect latent TB infections and prevent patients from developing the active form of this potentially deadly disease,” External link

4-traders Monday, January 7, 2019 10:44:00 AM EAT

Thierry Bernard précise : "Ce sont principalement des bricoles, trois-quatre tuiles envolées. C'est ennuyeux, mais il n'y a pas de gros dégâts. A part à Chamblet, où nous avons eu un sapin tombé sur une maison" External link

lamontagne Wednesday, March 8, 2017 3:21:00 AM EAT



Key Titles and Phrases Count Lang Last Seen
maire25.00%FR05/12/201712/05/2017
vice president25.00%EN05/02/201702/05/2017
directeur50.00%FR10/06/201606/10/2016
Names Lang Count
Thierry BernardFR80.00%
Thierry BernardDE10.00%
Thierry BernardEN10.00%


 
Show/hide duplicate news articles.
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Friday, August 14, 2020

8:54:00 PM EAT

Languages Collapse menu...Expand menu...

Select your languages

af
am
ar
de
en
es
fr
ha
pt
rw
sw
all
Show additional languagesHide additional languages

Interface:

Legend Collapse menu...Expand menu...


Quotes... Explore Relations


EMM Visual Explorer


AfricaBrief

Thierry Bernard

Last updated on 2017-05-12T08:07+0300.

About this image

sign

Quotes... Extracted quotes from

Thierry Bernard said : "The magnitude and duration of the global coronavirus pandemic have proven the increasingly critical importance of molecular testing to society. Qiagen’s business prospects have improved significantly," External link

channelnewsasia Thursday, August 13, 2020 5:30:00 PM EAT

Thierry Bernard said ( about Thermo Fisher Scientific ) : "After carefully considering the updated offer by Thermo Fisher , QIAGEN's Supervisory Board and Managing Board both unanimously recommend that shareholders accept this offer given that it reflects the improvements in our business performance and future prospects as a result of the coronavirus pandemic," External link

4-traders Thursday, July 16, 2020 3:53:00 PM EAT

Thierry Bernard said : “We are pleased to begin making QIAstat-Dx SARS-CoV-2 test kits available in the United States under the FDA’s emergency use authorisation for clinical laboratories. The QIAstat-Dx syndromic panel adds an important tool for clinicians,” External link

labmate-online Thursday, April 2, 2020 2:54:00 PM EAT

Thierry Bernard said : “We are pleased to begin making QIAstat-Dx SARS-CoV-2 test kits available in the United States as the first syndromic test not only to detect SARS-CoV-2, but also a range of more than 20 other respiratory targets. This is an important step in our commitment to offer a range of solutions to support the public health fight against COVID-19 and dramatically ramp up production” External link

neurope Tuesday, March 24, 2020 7:13:00 PM EAT

Thierry Bernard said : “We are pleased to begin making QIAstat-Dx SARS-CoV-2 test kits available in the United States as the first syndromic test not only to detect SARS-CoV-2, but also a range of more than 20 other respiratory targets. This is an important step in our commitment to offer a range of solutions to support the public health fight against COVID-19 and dramatically ramp up production,” External link

4-traders Tuesday, March 24, 2020 1:19:00 PM EAT

Thierry Bernard said : "We are pleased to launch the QIAstat-Dx SARS-CoV-2 test kits in Europe for clinical laboratories. QIAGEN is partnering with customers and public health authorities worldwide to provide a wide range of testing workflows, and the QIAstat-Dx syndromic panel adds an important tool for clinicians," External link

finanznachrichten-en Thursday, March 19, 2020 3:05:00 AM EAT

Thierry Bernard said : "QIAGEN teams are working 24/7 to address the unprecedented demand for reagents that has emerged to enable testing for COVID-19 in terms of RNA extraction, as well as for production of tests for use on the QIAstat-Dx syndromic testing system," External link

finanznachrichten-en Wednesday, March 18, 2020 1:02:00 AM EAT

Thierry Bernard says : "simple cartridge that goes into a very simple reader, which is the size of your laptop," External link

npr Wednesday, March 11, 2020 12:38:00 PM EAT

Thierry Bernard said ( about Thermo Fisher Scientific ) : "This strategic step with Thermo Fisher will enable us to enter a promising new era and will give our employees the opportunity to have an even greater impact. The combination is designed to deliver significant cash value to our shareholders," External link

xinhuanet_en Wednesday, March 4, 2020 2:03:00 AM EAT

Thierry Bernard said : "Our vision at QIAGEN has always been to make improvements in life possible with our differentiated Sample to Insight molecular testing solutions," External link

news-yahoo Tuesday, March 3, 2020 3:22:00 PM EAT

Thierry Bernard said : "Our vision at QIAGEN has always been to make improvements in life possible with our differentiated Sample to Insight molecular testing solutions," External link

news-yahoo Tuesday, March 3, 2020 11:32:00 AM EAT

Thierry Bernard said : "Our vision at QIAGEN has always been to make improvements in life possible with our differentiated Sample to Insight molecular testing solutions," External link

finanznachrichten-en Tuesday, March 3, 2020 11:29:00 AM EAT

Thierry Bernard sagte : "Wir freuen uns über die weitere Zusammenarbeit mit Amgen, denn sie basiert auf dem Erfolg unserer therascreen -Plattform und wird ein gewebebasiertes Begleitdiagnostikum entwickeln, um Patienten zu identifizieren, die von AMG510 profitieren würden. QIAGENs Sample to Insight-Workflows und die Erfahrung in der Entwicklung von Begleitdiagnostika für die Präzisionsmedizin sind sehr gut geeignet, um bei der Beurteilung von Patienten mit nicht-kleinzelligem Lungenkrebs zu helfen" External link

businesswire Tuesday, January 14, 2020 11:28:00 AM EAT

Thierry Bernard said : “We are pleased to support Amgen by building on the success of our therascreen platform to develop a tissue-based companion diagnostic to identify patients who would benefit from AMG510. QIAGEN’s Sample to Insight workflows and experience in developing diagnostic solutions for Precision Medicine are well-suited to help aid in evaluating patients with non-small cell lung cancer,” External link

businesswire Tuesday, January 14, 2020 11:28:00 AM EAT

Thierry Bernard said : "We are pleased to support Amgen by building on the success of our therascreen platform to develop a tissue-based companion diagnostic to identify patients who would benefit from AMG510. QIAGEN's Sample to Insight workflows and experience in developing diagnostic solutions for Precision Medicine are well-suited to help aid in evaluating patients with non-small cell lung cancer," External link

finanznachrichten-en Tuesday, January 14, 2020 1:12:00 AM EAT

Thierry Bernard sagte : "Wir freuen uns über die weitere Zusammenarbeit mit Amgen, denn sie basiert auf dem Erfolg unserer therascreen -Plattform und wird ein gewebebasiertes Begleitdiagnostikum entwickeln, um Patienten zu identifizieren, die von AMG510 profitieren würden. QIAGENs Sample to Insight-Workflows und die Erfahrung in der Entwicklung von Begleitdiagnostika für die Präzisionsmedizin sind sehr gut geeignet, um bei der Beurteilung von Patienten mit nicht-kleinzelligem Lungenkrebs zu helfen" External link

finanznachrichten-en Tuesday, January 14, 2020 1:12:00 AM EAT

Thierry Bernard said : “We are pleased to support Amgen by building on the success of our therascreen platform to develop a tissue-based companion diagnostic to identify patients who would benefit from AMG510. QIAGEN’s Sample to Insight workflows and experience in developing diagnostic solutions for Precision Medicine are well-suited to help aid in evaluating patients with non-small cell lung cancer,” External link

4-traders Tuesday, January 14, 2020 12:15:00 AM EAT

Thierry Bernard said : "2,500 cumulative QIAsymphony placements represent a great milestone for QIAGEN and are proof-point for a new era in laboratory automation that began in 2008. Today, QIAsymphony is considered a trusted workhorse in molecular testing labs worldwide whose continuous enhancements and ongoing menu expansion enabled numerous breakthroughs in science and helped diagnostic decision making to improve outcomes for over a million patients," External link

finanznachrichten-en Friday, January 10, 2020 12:45:00 AM EAT

Thierry Bernard sagte : „Wir freuen uns sehr über die FDA-Zulassung des LIAISON-QuantiFERON-TB Gold Plus Tests für den Einsatz auf der LIAISON-Plattform und den nun folgenden breitangelegten Marktstart dieser neuen Automatisierungsoption in den USA. Durch die Validierung der QuantiFERON-Technologie mit den LIAISON-Plattformen wurde das klinische Profil von QuantiFERON-TB Gold Plus weiter gestärkt“ External link

businesswire Thursday, November 28, 2019 1:08:00 AM EAT

Thierry Bernard said ( about Ekke Primauno ) : “We are pleased to announce FDA approval of the LIAISON QuantiFERON-TB Gold Plus Test for use on the LIAISON platform and the broad-based initiation of our launch for this new automation option in the United States. The validation of the QuantiFERON technology with the LIAISON platforms further reinforced the clinical profile of QuantiFERON-TB Gold Plus,” External link

businesswire Thursday, November 28, 2019 1:08:00 AM EAT

Thierry Bernard said ( about Ekke Primauno ) : “We are pleased to announce FDA approval of the LIAISON QuantiFERON-TB Gold Plus Test for use on the LIAISON platform and the broad-based initiation of our launch for this new automation option in the United States. The validation of the QuantiFERON technology with the LIAISON platforms further reinforced the clinical profile of QuantiFERON-TB Gold Plus,” External link

4-traders Wednesday, November 27, 2019 10:50:00 AM EAT

Thierry Bernard said : "Insights from our QIAstat-Dx syndromic testing solution offer real value for clinicians as rapid and efficient decision support for their evaluation of complex and sometimes life-threatening infections. This new study adds to the rapidly growing base of evidence that the QIAstat-Dx gastrointestinal panel delivers excellent results in an easy-to-use workflow," External link

finanznachrichten-en Wednesday, August 14, 2019 11:33:00 PM EAT

Thierry Bernard said : "We are pleased that UNAIDS selected QuantiFERON-TB Access for recognition at the Health Innovation Exchange. QIAGEN's drive to develop QFT Access springs from the need for a modern, accurate test for TB infection screening in areas where the disease burden is high but resources and infrastructure are scarce," External link

finanznachrichten-en Wednesday, May 22, 2019 1:01:00 AM EAT

Thierry Bernard said : “We are pleased that UNAIDS selected QuantiFERON-TB Access for recognition at the Health Innovation Exchange. QIAGEN’s drive to develop QFT Access springs from the need for a modern, accurate test for TB infection screening in areas where the disease burden is high but resources and infrastructure are scarce,” External link

4-traders Tuesday, May 21, 2019 11:54:00 PM EAT

Thierry Bernard sagt : "Wir freuen uns sehr über die Markteinführung des neuen therascreen FGFR-Kits, dem ersten von der FDA zugelassenen Begleitdiagnosetest zur Ermittlung von Alterationen im FGFR-Gen, der eine zielgerichtete Behandlung von Krebsindikationen ermöglicht. Durch den Einsatz unseres Tests zur Orientierung von Behandlungsentscheidungen bei Urothelkarzinomen wird ein hoher medizinischer Bedarf gedeckt" External link

finanznachrichten-en Saturday, April 13, 2019 7:14:00 AM EAT

Thierry Bernard said : "We are very excited about the launch of the new therascreen FGFR Kit, the first companion diagnostic test to obtain FDA approval for detection of FGFR gene alterations to guide therapy in any cancer indication. Using our test to help guide treatment decisions in urothelial cancer will address a high unmet medical need among patients," External link

finanznachrichten-en Friday, April 12, 2019 11:37:00 PM EAT

Thierry Bernard said : "NeuMoDx is aggressively ramping up the test menu for the NeuMoDx platforms to help clinical laboratories process increasing test volumes and deliver more rapid insights on a broad range of diseases. These new assays offer customers in Europe an expanding menu of infectious diseases, and we intend to continue rolling out new tests from a deep pipeline for a variety of diseases," External link

finanznachrichten-en Friday, April 12, 2019 12:30:00 AM EAT

Thierry Bernard said : "Our new QIAstat-Dx panel meets an urgent need for rapid and reliable diagnosis of meningitis and encephalitis infections, and will enable clinicians to select appropriate therapies in a timely manner. The panel delivers valuable insights with high sensitivity and specificity to identify these life-threatening syndromes," External link

finanznachrichten-en Friday, April 12, 2019 12:30:00 AM EAT

Thierry Bernard erklärte : "Unser neues QIAstat-Dx-Panel deckt den dringenden Bedarf an einer schnellen und zuverlässigen Diagnose von Meningitis/Enzephalitis ab und ermöglicht Ärzten damit die zeitnahe Wahl von geeigneten Therapien. Das Panel liefert wertvolle Erkenntnisse mit hoher Sensitivität und Spezifität für die Erkennung dieser lebensbedrohlichen Syndrome" External link

finanznachrichten-en Friday, April 12, 2019 12:30:00 AM EAT

Thierry Bernard said : “NeuMoDx is aggressively ramping up the test menu for the NeuMoDx platforms to help clinical laboratories process increasing test volumes and deliver more rapid insights on a broad range of diseases. These new assays offer customers in Europe an expanding menu of infectious diseases, and we intend to continue rolling out new tests from a deep pipeline for a variety of diseases,” External link

businesswire Thursday, April 11, 2019 11:36:00 PM EAT

Thierry Bernard said : "Our Day-One Lab Readiness program covers all the steps in being able to begin serving patients with access to companion diagnostic results immediately upon approval of new targeted therapies and the related companion diagnostics. Our Day-One program includes pre-approval preparation of workflow implementation, training, assay verification, forecasting, medical communication and reimbursement to ensure immediate readiness," External link

finanznachrichten-en Wednesday, April 3, 2019 11:57:00 PM EAT

Thierry Bernard said : “Our Day-One Lab Readiness program covers all the steps in being able to begin serving patients with access to companion diagnostic results immediately upon approval of new targeted therapies and the related companion diagnostics. Our Day-One program includes pre-approval preparation of workflow implementation, training, assay verification, forecasting, medical communication and reimbursement to ensure immediate readiness,” External link

businesswire Wednesday, April 3, 2019 11:35:00 PM EAT

Thierry Bernard said : "We are pleased to collaborate with Tecan, a proven leader with a track record of providing best-in-class liquid handling technology solutions, to further improve the automation of the pre-analytic manual steps leading to our QuantiFERON-TB Gold Plus test for customers," External link

finanznachrichten-en Friday, March 8, 2019 10:04:00 AM EAT

Thierry Bernard said : “QuantiFERON-TB Gold Plus is rapidly winning adoption in developed markets as an important way to detect latent TB infections and prevent patients from developing the active form of this potentially deadly disease,” External link

4-traders Monday, January 7, 2019 10:44:00 AM EAT

Thierry Bernard précise : "Ce sont principalement des bricoles, trois-quatre tuiles envolées. C'est ennuyeux, mais il n'y a pas de gros dégâts. A part à Chamblet, où nous avons eu un sapin tombé sur une maison" External link

lamontagne Wednesday, March 8, 2017 3:21:00 AM EAT



Key Titles and Phrases Count Lang Last Seen
maire25.00%FR05/12/201712/05/2017
vice president25.00%EN05/02/201702/05/2017
directeur50.00%FR10/06/201606/10/2016
Names Lang Count
Thierry BernardFR80.00%
Thierry BernardDE10.00%
Thierry BernardEN10.00%


<<10<12345678910>>>10
<<10<12345678910>>>10

Tools

Load latest edition

Friday, August 14, 2020

8:54:00 PM EAT


Quotes... Explore Relations


EMM Visual Explorer